ECHINOMYCIN (NSC-526417) IN SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP

被引：23

作者：

MUSS, HB

BLESSING, JA

MALFETANO, J

机构：

[1] ALBANY MED CTR,DEPT OBSTET & GYNECOL,ALBANY,NY

[2] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT MED,WINSTON SALEM,NC 27103

[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,DEPT STAT,BUFFALO,NY 14263

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1990年 / 13卷 / 03期

关键词：

D O I：

10.1097/00000421-199006000-00002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Twenty-eight evaluable patients with advanced or recurrent squamous-cell carcinoma of the cervix were treated with 1,500 μg/m2 of echinomycin every 4 weeks. All patients had prior chemotherapy. Two patients had partial responses (7% response, 95% confidence interval for response of 1 to 24%). The major toxicity was nausea and vomiting. Myelosuppression and other toxicity were modest. Echinomycin, at this dose and schedule, displays minimal activity in patients with squamous-cell carcinoma of the cervix who have had prior chemotherapy.

引用

页码：191 / 193

页数：3

共 50 条

[31] 5-FLUOROURACIL AND LOW-DOSE LEUCOVORIN IN THE TREATMENT OF RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A PHASE-II TRIAL OF THE GYNECOLOGIC-ONCOLOGY-GROUP
LOOK, KY
BLESSING, JA
MUSS, HB
PARTRIDGE, EE
MALFETANO, JH
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (06): : 497 - 499
[32] PHASE-II TRIAL OF VP-16-213 IN THE TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX AND ADENOCARCINOMA OF THE OVARY - GYNECOLOGIC ONCOLOGY GROUP-STUDY
SLAYTON, RE
CREASMAN, WT
PETTY, W
BUNDY, B
BLESSING, JA
CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 2089 - 2092
[33] TENIPOSIDE (VM-26) IN PATIENTS WITH NON-SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP
MUSS, HB
BUNDY, BN
GIVEN, FT
STEHMAN, FB
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (02): : 117 - 118
[34] A PHASE-II EVALUATION OF CISPLATIN AND 5-FLUOROURACIL IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
BONOMI, P
BLESSING, J
BALL, H
HANJANI, P
DISAIA, PJ
GYNECOLOGIC ONCOLOGY, 1989, 34 (03) : 357 - 359
[35] A phase II trial of gallium nitrate (NSC #15200) in nonsquamous cell carcinoma of the cervix - A gynecologic oncology group study
Malfetano, JH
Blessing, JA
Homesley, HD
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (06): : 495 - 497
[36] Topotecan in squamous cell carcinoma of the cervix: A phase II study of the gynecologic oncology group
Bookman, MA
Blessing, JA
Hanjani, P
Herzog, TJ
Andersen, WA
GYNECOLOGIC ONCOLOGY, 2000, 77 (03) : 446 - 449
[37] PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE VULVA AND CARCINOMA OF THE VAGINA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
SLAYTON, RE
BLESSING, JA
BEECHAM, J
DISAIA, PJ
CANCER TREATMENT REPORTS, 1987, 71 (09): : 869 - 870
[38] Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix - A gynecologic oncology group study
Garcia, Agustin A.
Blessing, John A.
Vaccarello, Luis
Roman, Lynda D.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (04): : 428 - 431
[39] A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix - A Gynecologic Oncology Group study
Plaxe, SC
Blessing, JA
Lucci, JA
Hurteau, JA
INVESTIGATIONAL NEW DRUGS, 2001, 19 (01) : 77 - 80
[40] Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: A phase II trial of the gynecologic oncology group
Mannel, RS
Blessing, JA
Boike, G
GYNECOLOGIC ONCOLOGY, 2000, 79 (01) : 64 - 66

← 1 2 3 4 5 →